The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol

BMC Psychiatry
Shelley F McMainJeffrey S Hoch

Abstract

Although Dialectical Behaviour Therapy (DBT) is an evidence-based psychosocial treatment for borderline personality disorder (BPD), the demand for it exceeds available resources. The commonly researched 12-month version of DBT is lengthy; this can pose a barrier to its adoption in many health care settings. Further, there are no data on the optimal length of psychotherapy for BPD. The aim of this study is to examine the clinical and cost-effectiveness of 6 versus 12 months of DBT for chronically suicidal individuals with BPD. A second aim of this study is to determine which patients are as likely to benefit from shorter treatment as from longer treatment. Powered for non-inferiority testing, this two-site single-blind trial involves the random assignment of 240 patients diagnosed with BPD to 6 or 12 months of standard DBT. The primary outcome is the frequency of suicidal or non-suicidal self-injurious episodes. Secondary outcomes include healthcare utilization, psychiatric and emotional symptoms, general and social functioning, and health status. Cost-effectiveness outcomes will include the cost of providing each treatment as well as health care and societal costs (e.g., missed work days and lost productivity). Assessments are ...Continue Reading

References

Dec 1, 1991·Archives of General Psychiatry·M M LinehanH L Heard
Jan 1, 1985·International Journal of Psychiatry in Medicine·R W CowdryR Davies
Jan 1, 1982·Addictive Behaviors·H A Skinner
Jul 1, 1994·The American Journal of Psychiatry·A D LesageM Loyer
Nov 1, 1995·Journal of Clinical Psychology·J H PattonE S Barratt
May 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·A T ChengK A Chan
Dec 22, 1999·The American Journal on Addictions·M M LinehanK A Comtois
Dec 29, 2000·Journal of Behavior Therapy and Experimental Psychiatry·G J Devilly, T D Borkovec
Feb 7, 2001·The American Journal of Psychiatry·D S BenderJ G Gunderson
Jun 29, 2001·Archives of General Psychiatry·S TorgersenV Cramer
Feb 5, 2002·Archives of Internal Medicine·Raz GrossMyrna M Weissman
Feb 1, 2002·Psychiatric Services : a Journal of the American Psychiatric Association·Charles R SwensonKelly Koerner
Jun 14, 2002·Biological Psychiatry·Andrew E SkodolLarry J Siever
Feb 4, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Roel VerheulWim Van Den Brink
Mar 5, 2003·Child Abuse & Neglect·David P BernsteinWilliam Zule
Jul 29, 2003·Psychiatric Services : a Journal of the American Psychiatric Association·Katherine Anne ComtoisPeter Roy-Byrne
Jan 22, 2004·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·David L Streiner
Jul 9, 2004·Journal of Personality Disorders·Donald W BlackNancy Hale
Aug 21, 2004·Medical Care·John E Brazier, Jennifer Roberts
Oct 29, 2004·Journal of Health Services Research & Policy·Julie Barber, Simon Thompson
Feb 3, 2005·Health Economics·Andrew BriggsSimon Thompson
Sep 24, 2005·Journal of Personality Disorders·Courtney L BaggeTimothy J Trull
Jan 27, 2006·The Cochrane Database of Systematic Reviews·C A BinksC Duggan
Oct 4, 2006·Clinical Psychology Review·E David Klonsky
Jan 12, 2007·Psychopathology·Martin BohusRolf-Dieter Stieglitz
Jun 2, 2007·The American Journal of Psychiatry·John F ClarkinOtto F Kernberg
Jun 5, 2007·European Psychiatry : the Journal of the Association of European Psychiatrists·A D I van AsseltJ L Severens
Jul 11, 2007·Statistical Methods in Medical Research·Michael G Kenward, James Carpenter
Sep 21, 2007·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Barbara StanleyRebecca Dulit
Mar 28, 2008·The Journal of Clinical Psychiatry·Djøra I SoetemanJan J V Busschbach

❮ Previous
Next ❯

Citations

May 30, 2019·Psychiatric Services : a Journal of the American Psychiatric Association·Evan A IliakisLois W Choi-Kain
May 10, 2020·Personality and Mental Health·Joel Paris
May 6, 2020·The Cochrane Database of Systematic Reviews·Ole Jakob StorebøErik Simonsen
Jul 24, 2020·Journal of Cognitive Psychotherapy·Katie Aafjes-van DoornGeetali Chitre
Mar 4, 2021·Nature and Science of Sleep·Jakub VanekVlastimil Nesnidal
Apr 23, 2021·The Cochrane Database of Systematic Reviews·Katrina G WittKeith Hawton

❮ Previous
Next ❯

Methods Mentioned

BETA
cognitive behavioural therapy

Software Mentioned

SASII

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.